Chavez-MacGregor M - Search Results

1

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry.

Brewster AM, Chavez-MacGregor M, Brown P. Brewster AM, et al. Lancet Oncol. 2014 Dec;15(13):e625-e634. doi: 10.1016/S1470-2045(14)70364-X. Epub 2014 Nov 24. Lancet Oncol. 2014. PMID: 25456381 Free PMC article. Review.

2

Breast Cancer (BC) and Severe COVID-19 (C-19) Outcomes: A Matched Analysis.

Sullivan M, Lei X, Giordano SH, Chavez-MacGregor M. Sullivan M, et al. Res Sq [Preprint]. 2023 Dec 14:rs.3.rs-3485880. doi: 10.21203/rs.3.rs-3485880/v1. Res Sq. 2023. Update in: Breast Cancer Res Treat. 2024 Jul;206(2):307-316. doi: 10.1007/s10549-024-07301-1 PMID: 38168222 Free PMC article. Updated. Preprint.

3

Breast cancer, neoadjuvant chemotherapy and residual disease.

Chávez-MacGregor M, González-Angulo AM. Chávez-MacGregor M, et al. Clin Transl Oncol. 2010 Jul;12(7):461-7. doi: 10.1007/s12094-010-0538-0. Clin Transl Oncol. 2010. PMID: 20615822 Review.

4

Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer.

Hernandez-Aya LF, Chavez-Macgregor M, Lei X, Meric-Bernstam F, Buchholz TA, Hsu L, Sahin AA, Do KA, Valero V, Hortobagyi GN, Gonzalez-Angulo AM. Hernandez-Aya LF, et al. J Clin Oncol. 2011 Jul 1;29(19):2628-34. doi: 10.1200/JCO.2010.32.1877. Epub 2011 May 23. J Clin Oncol. 2011. PMID: 21606433 Free PMC article.

5

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.

Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, Brown EN, Lee RT, Meric-Bernstam F, Sood AK, Conzen SD, Hortobagyi GN, Gonzalez-Angulo AM. Melhem-Bertrandt A, et al. J Clin Oncol. 2011 Jul 1;29(19):2645-52. doi: 10.1200/JCO.2010.33.4441. Epub 2011 May 31. J Clin Oncol. 2011. PMID: 21632501 Free PMC article.

6

Everolimus in the treatment of hormone receptor-positive breast cancer.

Chavez-MacGregor M, Gonzalez-Angulo AM. Chavez-MacGregor M, et al. Expert Opin Investig Drugs. 2012 Dec;21(12):1835-43. doi: 10.1517/13543784.2012.726218. Epub 2012 Sep 20. Expert Opin Investig Drugs. 2012. PMID: 22994502 Review.

7

Breast cancer in 2012: New drugs, new knowledge, new targets.

Chavez-MacGregor M, Gonzalez-Angulo AM. Chavez-MacGregor M, et al. Nat Rev Clin Oncol. 2013 Feb;10(2):75-6. doi: 10.1038/nrclinonc.2012.236. Epub 2013 Jan 8. Nat Rev Clin Oncol. 2013. PMID: 23296111 Review. No abstract available.

8

Mesothelin expression and survival outcomes in triple receptor negative breast cancer.

Parinyanitikul N, Blumenschein GR, Wu Y, Lei X, Chavez-Macgregor M, Smart M, Gonzalez-Angulo AM. Parinyanitikul N, et al. Clin Breast Cancer. 2013 Oct;13(5):378-84. doi: 10.1016/j.clbc.2013.05.001. Epub 2013 Jun 27. Clin Breast Cancer. 2013. PMID: 23810431 Free PMC article.

9

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes.

Chavez-Macgregor M, Liu S, De Melo-Gagliato D, Chen H, Do KA, Pusztai L, Fraser Symmans W, Nair L, Hortobagyi GN, Mills GB, Meric-Bernstam F, Gonzalez-Angulo AM. Chavez-Macgregor M, et al. Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):316-23. doi: 10.1158/1055-9965.EPI-13-0929. Epub 2013 Dec 2. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24296856 Free PMC article.

10

Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.

Gagliato Dde M, Gonzalez-Angulo AM, Lei X, Theriault RL, Giordano SH, Valero V, Hortobagyi GN, Chavez-Macgregor M. Gagliato Dde M, et al. J Clin Oncol. 2014 Mar 10;32(8):735-44. doi: 10.1200/JCO.2013.49.7693. Epub 2014 Jan 27. J Clin Oncol. 2014. PMID: 24470007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters